These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22835667)

  • 1. The year in heart failure.
    Owens AT; Jessup M
    J Am Coll Cardiol; 2012 Jul; 60(5):359-68. PubMed ID: 22835667
    [No Abstract]   [Full Text] [Related]  

  • 2. Projecting heart failure into bankruptcy in 2012?
    Stevenson LW
    Am Heart J; 2011 Jun; 161(6):1007-11. PubMed ID: 21641344
    [No Abstract]   [Full Text] [Related]  

  • 3. Usefulness of frailty profile for targeting older heart failure patients in disease management programs: a cost-effectiveness, pilot study.
    Pulignano G; Del Sindaco D; Di Lenarda A; Tarantini L; Cioffi G; Gregori D; Tinti MD; Monzo L; Minardi G
    J Cardiovasc Med (Hagerstown); 2010 Oct; 11(10):739-47. PubMed ID: 20736784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy.
    Rogers JG; Bostic RR; Tong KB; Adamson R; Russo M; Slaughter MS
    Circ Heart Fail; 2012 Jan; 5(1):10-6. PubMed ID: 22052901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Home monitoring should be the central element in an effective program of heart failure disease management.
    Konstam MA
    Circulation; 2012 Feb; 125(6):820-7. PubMed ID: 22331919
    [No Abstract]   [Full Text] [Related]  

  • 6. Jumping in before the water is hot: the need to support randomized controlled clinical trials.
    Epstein AE
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):867-9. PubMed ID: 15333076
    [No Abstract]   [Full Text] [Related]  

  • 7. Disease management program for the elderly with heart failure.
    Belardinelli R
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):318-9. PubMed ID: 17443095
    [No Abstract]   [Full Text] [Related]  

  • 8. [What is evidence-based?].
    Gerlach H
    Krankenpfl J; 2005; 43(1-3):54-5. PubMed ID: 15912843
    [No Abstract]   [Full Text] [Related]  

  • 9. Two-year outcome of a prospective, controlled study of a disease management programme for elderly patients with heart failure.
    Del Sindaco D; Pulignano G; Minardi G; Apostoli A; Guerrieri L; Rotoloni M; Petri G; Fabrizi L; Caroselli A; Venusti R; Chiantera A; Giulivi A; Giovannini E; Leggio F
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):324-9. PubMed ID: 17443097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring quality in heart failure: do we have the metrics?
    Bonow RO
    Circ Cardiovasc Qual Outcomes; 2008 Sep; 1(1):9-11. PubMed ID: 20031782
    [No Abstract]   [Full Text] [Related]  

  • 11. Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).
    Reed SD; Friedman JY; Velazquez EJ; Gnanasakthy A; Califf RM; Schulman KA
    Am Heart J; 2004 Jul; 148(1):122-8. PubMed ID: 15215801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shattuck Lecture--Hidden barriers to improvement in the quality of care.
    McNeil BJ
    N Engl J Med; 2001 Nov; 345(22):1612-20. PubMed ID: 11757509
    [No Abstract]   [Full Text] [Related]  

  • 13. Economic impact of heart failure in the United States: time for a different approach.
    O'Connell JB; Bristow MR
    J Heart Lung Transplant; 1994; 13(4):S107-12. PubMed ID: 7947865
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical trials to "real-world" heart failure: applying risk stratification to deliver personalized care.
    Baliga RR; Young JB
    Heart Fail Clin; 2011 Oct; 7(4):xi-xiv. PubMed ID: 21925425
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost effectiveness of cardiac resynchronization therapy in Greece: an analysis based on the CArdiac REsychronization in Heart Failure trial.
    Maniadakis N; Ekman M; Calvert MJ; Freemantle N; Karamalis M; Vardas P
    Europace; 2011 Nov; 13(11):1597-603. PubMed ID: 21821852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progress in basic and clinical study on heart failure].
    Yazaki Y
    Nihon Rinsho; 2007 May; 65 Suppl 5():1-3. PubMed ID: 17571358
    [No Abstract]   [Full Text] [Related]  

  • 17. New strategies for improving heart failure management: a primary care perspective.
    Basile J
    South Med J; 2001 Feb; 94(2):166-74. PubMed ID: 11235030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health plans and Medicare step up to eliminate costly variation.
    Burns J
    Manag Care; 2011 Dec; 20(12):30-2, 35. PubMed ID: 22259874
    [No Abstract]   [Full Text] [Related]  

  • 19. Heart failure: epidemiologic update.
    Hodges P
    Crit Care Nurs Q; 2009; 32(1):24-32. PubMed ID: 19077806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness of cardiac resynchronization therapy in the Nordic region: an analysis based on the CARE-HF trial.
    Blomström P; Ekman M; Lundqvist CB; Calvert MJ; Freemantle N; Lönnerholm S; Wikström G; Jönsson B
    Eur J Heart Fail; 2008 Sep; 10(9):869-77. PubMed ID: 18684664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.